Report Company Directory
- GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for Enterprise in Innovation by GlobeNewsWire
- GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals by GlobeNewsWire
- GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex by GlobeNewsWire
- GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex by GlobeNewsWire
- Raymond James Afternoon Notes - BSM, CDW, CRTO, EPAY, JLL, LMRK, TCPC, VNOM by Raymond James
- GWPH | Model Updated for 1Q21 Financial Results by Raymond James
- GWPH | Dropping Coverage Post Jazz Acquisition by Raymond James
- GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting by GlobeNewsWire
- CRDL | Ph I Data: Safe, Support 2H21 Ph II/III Trials | 4Q20: No Shoppers Sales, Cutting Rev. Est. by Raymond James
- Portfolio Strategy | Morning Brew - February 26, 2021 by Raymond James